Skip to content Skip to footer
U.S Indices Down as Markets wait Big tech results

U.S. Indices Decline, Markets Await Tech Earnings

The major indices in the United States fell for a third consecutive day on Tuesday as markets anticipated big tech earnings.

Wall Street Indices await results from silicon valley big tech companies

After the likes of Goldman Sachs and J.P. Morgan released Q1 numbers last week, big tech will start reporting its earnings today, starting with Netflix.

The streaming giant will be reporting its performance for the first quarter after today’s closing bell, with IBM to follow soon after.

Regarding Netflix, they are expected to report earnings per share of $2.97, while revenue is expected to have risen to $7.14 billion from $5.77 billion a year ago.

The company’s share price was down 0.37% as of writing, with the S&P 500, NASDAQ and Dow Jones also in the red.

FTSE 100 falls despite declining British unemployment

The UK’s FTSE 100 was down in today’s session, despite data showing the country’s unemployment rate had unexpectedly fallen.

Figures released by the Office for National Statistics showed that Britain’s unemployment rate fell for a second consecutive month in the latest report.

The jobless rate fell to 4.9% during December -to-February, despite the country being in lockdown during this period.

Although markets had expected the rate to come in at 5.1% for this period, many believe the UK’s furlough scheme helped employers keep a sizable portion of workers employed.

London’s FTSE 100 was down 2% at close of business.

J&J shares up despite vaccine blood clot risks

After warnings of blood clotting issues with AstraZeneca’s COVID-19 vaccine, European regulators today found similar risk with the Johnson & Johnson jab.

The European Medicines Agency today announced that, “The EMA’s safety committee concluded that a warning about unusual blood clots with low blood platelets should be added to the product information for COVID-19 Vaccine Janssen”.

EMA officials added that, “Healthcare professionals and people who will receive the vaccine should be aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within three weeks of vaccination”.

Despite this the group added that the benefits of the vaccine outweigh the risks, and markets seemed to have taken to this as J&J was trading 2.5% higher as of writing.

Quote of the day – “Do more of what works and less of what doesn’t.”

– Steve Clark

Tradeview Ltd. is not a portfolio manager or an investment advisor. This Market Report is for informational purposes only. Any statements made or opinions voiced in this Market Report do not constitute investment advice. The Tradeview Ltd. Market Report does not constitute a solicitation to buy or sell in the financial markets. Although the information contained in the Market Report comes from trusted sources, Tradeview Ltd. is not responsible for guaranteeing the accuracy, timeliness, completeness, or fitness of such sources. Tradeview Ltd. shall not be responsible for and disclaims all liability for any losses which may be suffered from access and use of the contents of the Tradeview Ltd. Market Report. Trading any financial instrument on margin, using leverage or otherwise involves considerable risk. Therefore, before deciding to participate in any style of trading, you should carefully consider your investment objectives, level of experience and risk appetite. Most importantly, do not invest money you cannot afford to lose. Consulting with your investment counselor, attorney, accountant or other professional upon whom you rely for guidance as to the appropriateness of an investment in any style of trading is recommended.

Tradeview Ltd.

Is licensed to carry on securities investment business and is regulated by the Cayman Islands Monetary Authority (CIMA) as a full securities broker-dealer. Tradeview conducts business pursuant to the Cayman Islands Securities Investment Business Law (SIBL) and its activities fall under the direct supervision of the Investments and Securities Division of CIMA.
Headquarters: 5th Floor Anderson Square, 64 Shedden Road, Georgetown, Grand Cayman, Cayman Islands KY1-1002, BWI.
Website: www.tradeviewforex.com

Tradeview Asia Ltd.

Is licensed and regulated by the Labuan Financial Services Authority (FSA) as a Money Broker, registration number LL15870 licensed to facilitate transactions in foreign exchange pursuant to Labuan Financial Services and Securities Act 2010, the Labuan Companies Act 1990 and the Labuan Business Activity Tax Act 1990.
Headquarters: International Business Financial Centre at Office 5, Jamie Business Center I, Unit F10, First Floor, Paragon Labuan, Jalan Mustapha, 87000 Labuan F.T.
Website: www.tvmgloballtd.com

Tradeview Europe Ltd.

Is licensed as a Category 2 Investment Service Company and is regulated by the Malta Financial Services Authority (MFSA). The Malta Financial Services Authority (MFSA) is the single regulator for financial services in Malta. MFSA is a fully autonomous public institution and reports to Parliament on an annual basis. The MFSA is a member of the European Banking Authority (EBA), the European Securities and Markets Authority (ESMA) and the International Organization of Securities Commissions (IOSCO) and is a signatory of the Multilateral Memorandum of Understanding with other European regulatory Institutions. Tradeview is authorized to provide financial services across multiple asset classes and is passported in the EU/EEA under MiFID II (EU Markets in Financial Instruments Directive).
Headquarters: 157 Archbishops Street, Valletta VLT Malta 1440.
Website: www.tradeview.eu

Tradeview Financial Markets S.A.C Global

Is authorized to conduct business pursuant to and in compliance with the General Law of Companies (LGS) promulgated by the government of Peru. Tradeview Financial Markets S.A.C is registered with the National Superintendence of Public Registries (SUNARP), company number 13089531. Tradeview Financial Markets S.A.C provides financial services in selected OTC derivative markets in compliance with all applicable government regulations.
Headquarters: Los Mirtos 239 Urb. San Eugenio, Lince, Lima, Perú.
Website: www.tradeviewlatam.com